Canaccord Genuity Downgrades STAAR Surgical Company To Hold

Analysts at Canaccord Genuity downgraded STAAR Surgical Company

from Buy to Hold. The price target for STAAR Surgical Company has been lowered from $16.00 to $12.00. STAAR Surgical Company shares have dropped 16.62% over the past 52 weeks, while the S&P 500 index has surged 13.56% in the same period. STAAR Surgical Company shares fell 5.71% to $10.41 in pre-market trading.